Mainz, Germany

Jorge Moreno Herrero

This inventor holds 2 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Biontech Se, Tron—translationale Onkologie an Der Universitátsmedizin Der Johannes Gutenberg—universität Mainz Gemeinnützige Gmbh. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jorge Moreno Herrero. Retrieved from https://idiyas.com/inventor/jorge-moreno-herrero

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.9

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jorge Moreno Herrero: Pioneering Innovator in RNA Formulations

Introduction:

Jorge Moreno Herrero, a dedicated inventor based in Mainz, DE, is a true pioneer in the world of technology. With a fervent passion for innovation, Jorge has dedicated his career to creating inventions that have a positive impact on society.

Latest Patents:

Jorge Moreno Herrero holds 1 patent for his groundbreaking invention titled "Formulation for administration of RNA." This patent encompasses compositions comprising polyplex formulations for the delivery of RNA to a target organ or cell, especially through intramuscular administration. These formulations consist of polyplex particles from single-stranded RNA and a polyalkyleneimine, encoding proteins of interest for pharmaceutical applications in humans and animals.

Career Highlights:

Jorge Moreno Herrero has made significant contributions to the field of biotechnology through his work with renowned companies such as BioNTech SE and TRON-Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH. His expertise in RNA formulations has led to the development of innovative pharmaceutical products for effective parenteral application.

Collaborations:

Throughout his career, Jorge has collaborated closely with esteemed professionals in the industry, including Ugur Sahin and Heinrich Haas. These collaborations have fostered a culture of innovation, leading to the advancement of cutting-edge technologies in the field of biomedicine.

Conclusion:

In conclusion, Jorge Moreno Herrero's unwavering commitment to innovation and his relentless pursuit of creating impactful inventions highlight him as a true trailblazer in the realm of technology. His contributions to RNA formulations have the potential to revolutionize the pharmaceutical industry, thereby benefiting both human and animal health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…